Literature DB >> 4731287

The absorption and excretion of ethosuximide.

R A Buchanan, A W Kinkel, T C Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4731287

Source DB:  PubMed          Journal:  Int J Clin Pharmacol        ISSN: 0300-9718


× No keyword cloud information.
  9 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.

Authors:  Gail D Anderson; Shahin Hakimian
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

Review 3.  Disposition of anticonvulsants in childhood.

Authors:  J I Morrow; A Richens
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

4.  Relationships between plasma theophylline clearance, liver volume and body weight in children and adults.

Authors:  J J Grygiel; H Ward; M Ogborne; A Goldin; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Factors influencing plasma concentrations of ethosuximide.

Authors:  G A Smith; L McKauge; D Dubetz; J H Tyrer; M J Eadie
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

Review 6.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 7.  Plasma level monitoring of anticonvulsants.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 8.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

9.  Ethosuximide plasma concentrations: influence of age and associated concomitant therapy.

Authors:  D Battino; C Cusi; S Franceschetti; A Moise; S Spina; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.